The US Food and Drug Administration which has put on hold the phase 2/ 3 clinical trials of Bharat Biotech's Covid-19 vaccine Covaxin, in USA, has lifted the pause, according to a statement issued by Ocugen Inc, Bharat Biotech's partner for the jab in USA and Canada.from US News Headlines, Latest USA News, US news live on Times of India https://ift.tt/9k3jBCK
No comments:
Post a Comment